Centro di Riferimento Oncologico IRCCS

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread	Metastatic Urothelial Cancer	Active, not recruiting	Phase 2	2026-09-01		NCT03547973
BRCA Mutation Carriers' Platform a Multicenter Study	BRCA1 Mutation; BRCA2 Mutation	Recruiting	Not stated	2025-11-28		NCT07253051

Clinical trials